Kalemkerian GP - Search Results

1

High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study.

Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, Kalemkerian GP, Hayman JA. Kong FM, et al. Among authors: kalemkerian gp. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):324-33. doi: 10.1016/j.ijrobp.2005.02.010. Int J Radiat Oncol Biol Phys. 2005. PMID: 16168827

2

Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer.

Ali MA, Kraut MJ, Valdivieso M, Herskovic AM, Du W, Kalemkerian GP. Ali MA, et al. Among authors: kalemkerian gp. Lung Cancer. 1998 Oct;22(1):39-44. doi: 10.1016/s0169-5002(98)00064-6. Lung Cancer. 1998. PMID: 9869106 Clinical Trial.

3

Lung cancer in patients < 50 years of age: the experience of an academic multidisciplinary program.

Gadgeel SM, Ramalingam S, Cummings G, Kraut MJ, Wozniak AJ, Gaspar LE, Kalemkerian GP. Gadgeel SM, et al. Among authors: kalemkerian gp. Chest. 1999 May;115(5):1232-6. doi: 10.1378/chest.115.5.1232. Chest. 1999. PMID: 10334132

4

Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer.

Kalemkerian GP, Belzer K, Wozniak AJ, Gaspar LE, Valdivieso M, Kraut MJ. Kalemkerian GP, et al. Lung Cancer. 1999 Sep;25(3):175-82. doi: 10.1016/s0169-5002(99)00060-4. Lung Cancer. 1999. PMID: 10512128 Clinical Trial.

5

A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.

Ali MA, Kraut MJ, Valdivieso M, Wozniak AJ, Cummings G, Kalemkerian GP. Ali MA, et al. Among authors: kalemkerian gp. Cancer Invest. 2000;18(1):1-5. doi: 10.3109/07357900009023055. Cancer Invest. 2000. PMID: 10701360 Clinical Trial.

6

Therapeutic advances in small cell lung cancer.

Worden FP, Kalemkerian GP. Worden FP, et al. Among authors: kalemkerian gp. Expert Opin Investig Drugs. 2000 Mar;9(3):565-79. doi: 10.1517/13543784.9.3.565. Expert Opin Investig Drugs. 2000. PMID: 11060696 Review.

7

Lung cancer.

Worden FP, Kalemkerian GP. Worden FP, et al. Among authors: kalemkerian gp. Cancer Treat Res. 2001;106:183-219. doi: 10.1007/978-1-4615-1657-6_8. Cancer Treat Res. 2001. PMID: 11225003 Review. No abstract available.

8

A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer.

Kalemkerian GP, Ali MA, Luthra K, Wozniak AJ, Valdivieso M, Kraut MJ. Kalemkerian GP, et al. Cancer Invest. 2001;19(3):234-8. doi: 10.1081/cnv-100102549. Cancer Invest. 2001. PMID: 11338879 Clinical Trial.

9

Unusual presentations of lung cancer: Case 1. Diabetes insipidus as the initial manifestation of non-small-cell lung cancer.

Reddy P, Kalemkerian GP. Reddy P, et al. Among authors: kalemkerian gp. J Clin Oncol. 2002 Dec 1;20(23):4597-8. doi: 10.1200/JCO.2002.20.23.4597. J Clin Oncol. 2002. PMID: 12454118 No abstract available.

10

Unusual presentations of lung cancer: Case 2. Adrenal insufficiency as the initial manifestation of non-small-cell lung cancer.

Sirachainan E, Kalemkerian GP. Sirachainan E, et al. Among authors: kalemkerian gp. J Clin Oncol. 2002 Dec 1;20(23):4598-600. doi: 10.1200/JCO.2002.20.23.4598. J Clin Oncol. 2002. PMID: 12454119 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters